Holen Sie sich die Stockscreener-App
652.25
2.48%
-16.44
Schlusskurs vom Vortag:
$668.69
Offen:
$669.97
24-Stunden-Volumen:
10.18M
Relative Volume:
0.60
Marktkapitalisierung:
$1.65T
Einnahmen:
$200.97B
Nettoeinkommen (Verlust:
$60.46B
KGV:
27.77
EPS:
23.4909
Netto-Cashflow:
$46.11B
1W Leistung:
-2.70%
1M Leistung:
+1.58%
6M Leistung:
-17.45%
1J Leistung:
-10.10%
1-Tages-Spanne:
$645.28
$676.00
1-Wochen-Bereich:
$645.28
$683.31
52-Wochen-Spanne:
$479.80
$796.25
Meta Platforms Inc Stock (META) Company Profile
Firmenname
Meta Platforms Inc
Sektor
Telefon
650-543-4800
Adresse
1 META WAY, MENLO PARK
Compare META vs GOOG, GOOGL, SPOT, DASH
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
META
Meta Platforms Inc
|
652.17 | 1.69T | 200.97B | 60.46B | 46.11B | 23.49 |
|
GOOG
Alphabet Inc
|
310.91 | 3.77T | 403.06B | 132.17B | 73.27B | 10.81 |
|
GOOGL
Alphabet Inc
|
310.66 | 3.76T | 403.06B | 132.17B | 73.27B | 10.81 |
|
SPOT
Spotify Technology S A
|
448.50 | 100.28B | 18.68B | 1.58B | 3.29B | 6.4096 |
|
DASH
Doordash Inc
|
164.25 | 75.63B | 12.64B | 858.00M | 1.99B | 1.9711 |
Meta Platforms Inc Stock (META) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-29 | Bestätigt | Canaccord Genuity | Buy |
| 2026-01-29 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2026-01-29 | Bestätigt | Deutsche Bank | Buy |
| 2026-01-29 | Bestätigt | Evercore ISI | Outperform |
| 2026-01-29 | Bestätigt | Guggenheim | Buy |
| 2026-01-29 | Bestätigt | JP Morgan | Overweight |
| 2026-01-29 | Bestätigt | Jefferies | Buy |
| 2026-01-29 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-01-29 | Bestätigt | Mizuho | Outperform |
| 2026-01-29 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2026-01-29 | Bestätigt | Morgan Stanley | Overweight |
| 2026-01-29 | Bestätigt | Piper Sandler | Overweight |
| 2026-01-29 | Bestätigt | Pivotal Research Group | Buy |
| 2026-01-29 | Bestätigt | Robert W. Baird | Outperform |
| 2026-01-29 | Bestätigt | Roth Capital | Buy |
| 2026-01-29 | Bestätigt | Stifel | Buy |
| 2026-01-29 | Bestätigt | UBS | Buy |
| 2026-01-29 | Bestätigt | Wedbush | Outperform |
| 2026-01-29 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-29 | Bestätigt | Wolfe Research | Outperform |
| 2026-01-26 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-01-26 | Bestätigt | Raymond James | Strong Buy |
| 2026-01-26 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2026-01-23 | Bestätigt | Stifel | Buy |
| 2026-01-13 | Bestätigt | TD Cowen | Buy |
| 2026-01-12 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-08 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2026-01-08 | Bestätigt | Guggenheim | Buy |
| 2025-12-04 | Hochstufung | Arete | Neutral → Buy |
| 2025-11-24 | Eingeleitet | BNP Paribas Exane | Outperform |
| 2025-11-10 | Herabstufung | Erste Group | Buy → Hold |
| 2025-10-30 | Bestätigt | Barclays | Overweight |
| 2025-10-30 | Bestätigt | Bernstein | Outperform |
| 2025-10-30 | Bestätigt | BofA Securities | Buy |
| 2025-10-30 | Bestätigt | Citigroup | Buy |
| 2025-10-30 | Bestätigt | JP Morgan | Overweight |
| 2025-10-30 | Bestätigt | Jefferies | Buy |
| 2025-10-30 | Bestätigt | Mizuho | Outperform |
| 2025-10-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-10-30 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-10-30 | Bestätigt | Piper Sandler | Overweight |
| 2025-10-30 | Bestätigt | Stifel | Buy |
| 2025-10-30 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2025-10-20 | Bestätigt | Oppenheimer | Outperform |
| 2025-10-07 | Bestätigt | Wells Fargo | Overweight |
| 2025-09-30 | Eingeleitet | Mizuho | Outperform |
| 2025-07-31 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-07-31 | Bestätigt | Bernstein | Outperform |
| 2025-07-31 | Bestätigt | BofA Securities | Buy |
| 2025-07-31 | Bestätigt | Citigroup | Buy |
| 2025-07-31 | Bestätigt | Citizens JMP | Mkt Outperform |
| 2025-07-31 | Bestätigt | JP Morgan | Overweight |
| 2025-07-31 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2025-07-31 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-07-31 | Bestätigt | Morgan Stanley | Overweight |
| 2025-07-31 | Bestätigt | Oppenheimer | Outperform |
| 2025-07-31 | Bestätigt | Pivotal Research Group | Buy |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-31 | Bestätigt | UBS | Buy |
| 2025-07-31 | Bestätigt | Wedbush | Outperform |
| 2025-07-31 | Bestätigt | Wells Fargo | Overweight |
| 2025-07-28 | Bestätigt | Guggenheim | Buy |
| 2025-07-16 | Bestätigt | Canaccord Genuity | Buy |
| 2025-07-03 | Hochstufung | Needham | Underperform → Hold |
| 2025-06-26 | Bestätigt | UBS | Buy |
| 2025-06-24 | Bestätigt | Citigroup | Buy |
| 2025-05-01 | Bestätigt | BofA Securities | Buy |
| 2025-05-01 | Bestätigt | Citigroup | Buy |
| 2025-05-01 | Bestätigt | Evercore ISI | Outperform |
| 2025-05-01 | Bestätigt | Goldman | Buy |
| 2025-05-01 | Bestätigt | Guggenheim | Buy |
| 2025-05-01 | Bestätigt | JP Morgan | Overweight |
| 2025-05-01 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2025-05-01 | Bestätigt | MoffettNathanson | Buy |
| 2025-05-01 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-05-01 | Bestätigt | Morgan Stanley | Overweight |
| 2025-05-01 | Bestätigt | Oppenheimer | Outperform |
| 2025-05-01 | Bestätigt | Piper Sandler | Overweight |
| 2025-05-01 | Bestätigt | Pivotal Research Group | Buy |
| 2025-05-01 | Bestätigt | Raymond James | Strong Buy |
| 2025-05-01 | Bestätigt | Rosenblatt | Buy |
| 2025-05-01 | Bestätigt | Roth Capital | Buy |
| 2025-05-01 | Bestätigt | Stifel | Buy |
| 2025-05-01 | Bestätigt | Truist | Buy |
| 2025-05-01 | Bestätigt | UBS | Buy |
| 2025-05-01 | Bestätigt | Wedbush | Outperform |
| 2025-04-14 | Bestätigt | Citigroup | Buy |
| 2025-04-10 | Bestätigt | Piper Sandler | Overweight |
| 2025-01-30 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2025-01-23 | Bestätigt | BofA Securities | Buy |
| 2025-01-22 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2025-01-06 | Bestätigt | Jefferies | Buy |
| 2025-01-03 | Bestätigt | Wolfe Research | Outperform |
| 2024-10-31 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-10-31 | Bestätigt | Pivotal Research Group | Buy |
| 2024-10-11 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-09 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2024-10-01 | Eingeleitet | Pivotal Research Group | Buy |
| 2024-09-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-09-10 | Eingeleitet | DA Davidson | Buy |
| 2024-09-05 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-01 | Bestätigt | BofA Securities | Buy |
| 2024-07-19 | Bestätigt | Oppenheimer | Outperform |
| 2024-07-16 | Eingeleitet | Wolfe Research | Outperform |
| 2024-07-10 | Bestätigt | TD Cowen | Buy |
| 2024-07-08 | Bestätigt | Wells Fargo | Overweight |
| 2024-07-01 | Bestätigt | Raymond James | Strong Buy |
| 2024-06-12 | Bestätigt | BMO Capital Markets | Market Perform |
| 2024-05-02 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2024-04-25 | Bestätigt | Oppenheimer | Outperform |
| 2024-04-15 | Bestätigt | Citigroup | Buy |
| 2024-04-11 | Bestätigt | Piper Sandler | Overweight |
| 2024-04-08 | Bestätigt | Oppenheimer | Outperform |
| 2024-04-04 | Bestätigt | Jefferies | Buy |
| 2024-02-02 | Bestätigt | Guggenheim | Buy |
| 2024-02-02 | Bestätigt | JMP Securities | Mkt Outperform |
| 2024-02-02 | Bestätigt | JP Morgan | Overweight |
| 2024-02-02 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2024-02-02 | Bestätigt | Mizuho | Buy |
| 2024-02-02 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-02-02 | Bestätigt | Morgan Stanley | Overweight |
| 2024-02-02 | Bestätigt | Oppenheimer | Outperform |
| 2024-02-02 | Bestätigt | Piper Sandler | Overweight |
| 2024-02-02 | Bestätigt | ROTH MKM | Buy |
| 2024-02-02 | Bestätigt | Raymond James | Strong Buy |
| 2024-02-02 | Bestätigt | Robert W. Baird | Outperform |
| 2024-02-02 | Bestätigt | Seaport Research Partners | Buy |
| 2024-02-02 | Bestätigt | Stifel | Buy |
| 2024-02-02 | Bestätigt | Susquehanna | Positive |
| 2024-02-02 | Bestätigt | TD Cowen | Outperform |
| 2024-02-02 | Bestätigt | UBS | Buy |
| 2024-02-02 | Bestätigt | Wedbush | Outperform |
| 2024-02-02 | Bestätigt | Wells Fargo | Overweight |
| 2024-02-02 | Bestätigt | Wolfe Research | Outperform |
| 2024-01-23 | Bestätigt | Citigroup | Buy |
| 2024-01-17 | Bestätigt | Piper Sandler | Overweight |
| 2024-01-17 | Bestätigt | Wells Fargo | Overweight |
| 2024-01-09 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2023-12-20 | Fortgesetzt | Raymond James | Strong Buy |
| 2023-10-24 | Eingeleitet | Seaport Research Partners | Buy |
| 2023-08-22 | Eingeleitet | Wedbush | Outperform |
| 2023-08-01 | Bestätigt | Argus | Buy |
| 2023-07-28 | Hochstufung | China Renaissance | Hold → Buy |
| 2023-07-27 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2023-07-27 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-07-25 | Bestätigt | Mizuho | Buy |
| 2023-07-25 | Hochstufung | New Street | Neutral → Buy |
| 2023-07-19 | Bestätigt | Jefferies | Buy |
| 2023-07-19 | Bestätigt | Truist | Buy |
| 2023-07-17 | Bestätigt | Credit Suisse | Outperform |
| 2023-07-17 | Bestätigt | Goldman | Buy |
| 2023-07-17 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-07-13 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-07-12 | Bestätigt | Deutsche Bank | Buy |
| 2023-06-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-05-15 | Hochstufung | Loop Capital | Hold → Buy |
| 2023-04-27 | Bestätigt | Credit Suisse | Outperform |
| 2023-04-27 | Bestätigt | Deutsche Bank | Buy |
| 2023-04-27 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-27 | Bestätigt | Goldman | Buy |
| 2023-04-27 | Bestätigt | Guggenheim | Buy |
| 2023-04-27 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-04-27 | Bestätigt | JP Morgan | Overweight |
| 2023-04-27 | Bestätigt | Mizuho | Buy |
| 2023-04-27 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2023-04-27 | Bestätigt | Morgan Stanley | Overweight |
| 2023-04-27 | Bestätigt | Oppenheimer | Outperform |
| 2023-04-27 | Bestätigt | Piper Sandler | Overweight |
| 2023-04-27 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-27 | Bestätigt | Raymond James | Outperform |
| 2023-04-27 | Bestätigt | Robert W. Baird | Outperform |
| 2023-04-27 | Bestätigt | Rosenblatt | Buy |
| 2023-04-27 | Bestätigt | Stifel | Buy |
| 2023-04-27 | Bestätigt | TD Cowen | Market Perform |
| 2023-04-27 | Bestätigt | Truist | Buy |
| 2023-04-27 | Bestätigt | Wolfe Research | Outperform |
Alle ansehen
Meta Platforms Inc Aktie (META) Neueste Nachrichten
Stock-Split Watch: Is Meta Platforms Next? - The Motley Fool
Are Big Tech firms the new tobacco companies? - The Week
Uh-Oh! Is Meta Platforms Following in Enron’s Footsteps? - 24/7 Wall St.
Activist investor Bill Ackman makes $2B bet on Meta Platforms - Yahoo Finance
Billionaire Investor Bill Ackman Just Bought A New Stock and It's My #1 Position - The Motley Fool
Meta trial reaches day four after former senior staffer testimony - KOAT
Reddit Stock Declines 46% in a Month: Should You Buy, Hold or Sell? - Yahoo Finance Singapore
Veltria Advisors Corp. Cuts Stock Position in Meta Platforms, Inc. $META - MarketBeat
Wallace Hart LLC Invests $621,000 in Meta Platforms, Inc. $META - MarketBeat
WCM Investment Management LLC Sells 942 Shares of Meta Platforms, Inc. $META - MarketBeat
Meta’s US$10b Indiana AI Hub Tests Capex And Regulation Balance - Yahoo Finance UK
Pershing Square's Bill Ackman buys Meta believing AI fears undervalue one of "world's greatest businesses" - QuotedData
Child exploitation, grooming, and social media addiction claims put Meta on trial - Malwarebytes
Meta Platforms: Snatch Up This Big Tech Deal Now (NASDAQ:META) - Seeking Alpha
Former Facebook staffer testifies in Meta trial - KOAT
Fund Update: 56,723 META PLATFORMS (META) shares added to FIRST FINANCIAL BANKSHARES INC portfolio - Quiver Quantitative
Peterson Wealth Services Has $2.10 Million Stock Position in Meta Platforms, Inc. $META - MarketBeat
Meta Platforms, Inc. $META Shares Purchased by Raleigh Capital Management Inc. - MarketBeat
Russia fully blocks WhatsApp, talks up state-backed alternative - NBC News
1 Growth Stock to Add to Your Roster and 2 We Brush Off - The Globe and Mail
Hartford Investment Management Co. Sells 3,904 Shares of Meta Platforms, Inc. $META - MarketBeat
Meta Platforms, Inc. $META Holdings Cut by Callan Family Office LLC - MarketBeat
Filmmaker Ami Horowitz discusses Meta CEO Mark Zuckerberg’s move from Gavin Newsom’s California, where he has reportedly purchased a waterfront mansion in red-state Florida. - facebook.com
WhatsApp Says Russia Tries to Block Its Messaging Service - Yahoo Finance
Mark Zuckerberg is joining Jeff Bezos in Miami’s billionaire bunker: Take a look inside his real-estate portfolio - Fortune
EssilorLuxottica Growth Propelled by Meta Glasses Sales Boom - Bloomberg
Instagram chief says he does not believe people can get clinically addicted to social media in testimony at landmark trial - ABC7 Los Angeles
SCS Capital Management trims Meta Platforms stake by 1,035 shares - TipRanks
Crake Asset Management Boosts Meta Platforms Stake by 6,500 Shares - TipRanks
Ex-Facebook exec testifies Meta's tools not effective at blocking harmful content - Santa Fe New Mexican
WhatsApp says Russia tried to fully block service to push state app - WKZO
Meta attorneys challenge former Facebook Staffer Testimony - KOAT
WhatsApp accuses Russia of trying to fully block its service to favour state app - Reuters
Instagram head testifies in landmark trial on social media, kids - Good Morning America
Russia blocks Meta's WhatsApp messaging service, FT reports - Yahoo
Meta Platforms (NASDAQ:META) COO Sells $342,869.23 in Stock - MarketBeat
Bill Ackman Makes a Big Bet On Meta - The Wall Street Journal
Instagram chief says he does not believe people can get clinically addicted to social media - KSL NewsRadio
Instagram chief likens social media addiction to being hooked on a Netflix show in trial testimony - CNBC
Pershing’s Ackman Reveals New Stakes in Meta, Amazon, and Hertz - Barron's
Ray-Ban parent company: Meta AI glasses sales grew more than threefold last year. - 富途牛牛
Bill Ackman Makes a Big Bet on MetaWSJ - The Wall Street Journal
Meta Is Quietly Building a New Moat: Is META Stock A Buy Now? - Yahoo Finance
Pershing Square takes sizable Meta stake amid tech realignment - Investing.com
Ackman's hedge fund Pershing Square bets on Meta, exits Hilton - Reuters
Tech Voices: Pershing Square-Meta, Cloudflare, ByteDance-Samsung chips - Seeking Alpha
Meta breaks ground on its $10B data center in Indiana (META:NASDAQ) - Seeking Alpha
Meta begins construction on $10B data center campus at LEAP District in Lebanon - Indianapolis Business Journal
Meta Platforms Is Preparing for AI's "iPhone Moment": Is the Stock a Buy? - Yahoo Finance
EssilorLuxottica Growth Propelled by Boom in Meta Glasses Sales - The Business of Fashion
Bill Ackman’s Pershing Square Discloses New Major Stake in Meta - Bloomberg
Finanzdaten der Meta Platforms Inc-Aktie (META)
Umsatz
Nettogewinn
Free Cashflow
ENV
7.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):